Mobile, Security, Big Data, IOT, AI/ML, Cloud Computing, MedTech/Health, Web, SaaS
Сотрудники ≈ 12
Технические специалисты в Беларуси ≈ 6
Сотрудники в Беларуси ≈ 7
2014 год основания

The Dutch-based Medvision360 BV is specialized in delivering high quality, secure eHealth solutions. Where stability, reliability and continuous availability of software are key to our business success. We create innovative and complex web and mobile applications, based on the latest technology.

In the previous years, we have been working on our MEDrecord platform, which is completely standardized with open REST API’s. Jan-Marc Verlinden, is the Managing Director and founder of Medvision360 (MEDrecord). Jan-Marc is a successful eHealth innovator in The Netherlands. With these new projects, Jan-Marc aims to become one of the major players in the eHealth domain.

For the next two years, we have started several European projects. In these projects, we will (for instance) monitor patients with heart failure at home, and we need to add Artificial Intelligence on top of EEG datasets for epilepsy patients and we need to develop an AI-based chatbot for elderly. For this, we need to connect to various devices, but also services like Google Fit, and make “something” out of all of this huge datasets. Our codebase exists of 

• Microservices based backend and API’s

• API’s are based on FHIR, check

• The client side is Angular 2+ with CSS

Within the upcoming two years, it is our intention to go to the market and become one of the major players in the eHealth domain. For this, we are setting up a new development team.

We do this with our two brands: 1. MEDrecord is an eHealth platform as a service, please check

2. MedSafe is one of the 12 Personal Health Environments in The Netherlands, please check

Данная компания не может участвовать в рейтинге. Почему?

Официальные представители

  • user113735 менеджер по персоналу

В компании работают


Ранее в компании работали

Войдите, чтобы оставить отзыв и оценить компанию
Перепечатка материалов возможна только с письменного разрешения редакции.
При цитировании обязательна прямая гиперссылка на соответствующие материалы. Пишите на